tm
Seeing Is Believing
tm
Seeing Is Believing
LENZ is currently covered by 2 analysts with an average price target of $56.24. This is a potential upside of $14.95 (36.21%) from yesterday's end of day stock price of $41.29.
LENZ Therapeutics's activity chart (see below) currently has 0 price targets and 5 ratings on display. The stock rating distribution of LENZ is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 83.33% with an average time for these price targets to be met of 236.5 days.
Highest price target for LENZ is $48, Lowest price target is $48, average price target is $42.
Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 28-Jul-2025. First documented stock forecast 27-Mar-2024.
Currently out of the existing stock ratings of LENZ, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$48
$6.66 (16.11%)
$38
1 months 20 days ago
(28-Jul-2025)
2/3 (66.67%)
$16.49 (52.33%)
321
Buy
$36
$-5.34 (-12.92%)
$28
1 years 1 months 2 days ago
(15-Aug-2024)
2/2 (100%)
$13.4 (59.29%)
152
What is LENZ (LENZ Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LENZ (LENZ Therapeutics) with a proven track record?
Which analyst has the current lower performing score on LENZ (LENZ Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LENZ (LENZ Therapeutics)?
Which analyst is the currently most bullish on LENZ (LENZ Therapeutics)?
Which analyst is the currently most reserved on LENZ (LENZ Therapeutics)?
